[c09aa8]: / clusters / final9knumclusters / clust_1674.txt

Download this file

38 lines (37 with data), 3.2 kB

 1
 2
 3
 4
 5
 6
 7
 8
 9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
Urine M-Protein >= 200 mg/24 hours, OR
Urine M-protein ?200 mg/24 hours ; or
Urine M-protein level >= 200 milligram per 24 hours (mg/24 hours); or
Urine M-protein ?200 mg/24 hours (any immunoglobulin heavy chain type measured by PEP).
Urine M-protein > 200 mg/24 hours
Serum M-protein level >=1.0 gram per deciliter (g/dL) or urine M-protein level >=200 mg/24 hours; or
Urine M-protein ?200 mg/24 hours and must have documented MM isotype by immunofixation (central laboratory).
Urine M-protein ? 200 mg/24 hours OR
Urine M protein ? 200 mg/24 hours), or
Urine M-protein =< 1 g/24 hours (MM patients only)
urine M-protein ?200 mg/24 hours.
Urine M-protein ?200 mg/24 hours, OR
urine M-protein ? 200 mg/24 hours,
Urinary protein >2+ possibly indicative of renal disease. If the 24 hours urine protein shows a result of < 100 mg protein, subject can be eligible;
Urine M protein ? 200 mg/24 hours
IgG MM: Serum monoclonal paraprotein (M-protein) level ? 1.0 g/dl or urine Mprotein level ? 200 mg/24 hours- IgA MM: Serum M-protein level ? 0.5 g/dl or urine M-protein level ? 200 mg/24 hours
IgM MM (IgM M-protein plus lytic bone disease documented by skeletal survey plain films): Serum M-protein level ? 1.0 g/dl or urine M-protein level ? 200 mg/24 hours
IgD MM: Serum M-protein level ? 0.05 g/dl or urine M-protein level ? 200 mg/24 hours
Light chain MM: Serum M-protein level ? 1.0 g/dl or urine M-protein level ? 200 mg/24 hours 5. Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 6. Females of childbearing potential (FCBP1) must:
Urine M protein ?200 mg/24 hours;
Urine protein =< 1+ on urine dipstick (if 2+ seen on first test, re-test at least 24 hours later), within 14 days of study registration
Urine M-protein ? 200 mg/24 hours
Relapsed and/or refractory multiple myeloma with measurable disease, as defined by one or both of the following (assessed within 14 days prior to initiation of therapy): a) serum myeloma protein (M-protein) >= 0.5 g/d; b) urine Bence-Jones protein >= 200 mg/24 hours
Urine M-protein ? 200 mg/24 hours.
Urine M-protein ? 200 mg/24 hours
Urine M-protein ? 200 mg/24 hours OR
Urine M-protein ? 200 mg/24 hours, or
Urine Bence-Jones protein ? 200 mg/24 hours
IgG multiple myeloma: Serum monoclonal paraprotein (M-protein) level ? 1.0 g/dl or urine M-protein level ? 200 mg/24 hours
IgA multiple myeloma: Serum M-protein level ? 0.5 g/dl or urine M-protein level ? 200 mg/24 hours
IgM multiple myeloma (IgM M-protein plus lytic bone disease documented by skeletal survey plain films): Serum M-protein level ? 1.0 g/dl or urine M-protein level ? 200mg/24hours
IgD multiple myeloma: Serum M-protein level ? 0.05 g/dl or urine M-protein level ? 200 mg/24 hours
Light chain multiple myeloma: Serum M-protein level ? 1.0 g/dl or urine M-protein level ? 200 mg/24 hours AND are at least 65 years of age or older or, if younger than 65 years of age, are not candidates for stem cell transplantation because:
Urinary M-protein excretion at least 200 mg/24 hours; or
Urinary M-protein excretion at least 200 mg/24 hours; or
Urine protein =< 1+ on urine dipstick (if 2+ seen on first test, re-test at least 24 hours later) (within 14 days of study registration)
Urine M-protein >=200 mg/24 hours.